Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...] …
Category: Providers
Japanese pharmaceutical manufacturer Eisai will not limit hospital 340B contract pharmacy use in Arkansas and Louisiana after its new contract [...] …
Drugmaker Bristol Myers Squibb added new language to its latest 340B contract pharmacy policy notice, which appears to target hospital [...] …
The deadline has passed for two health systems to respond to an influential senator’s probe into 340B revenue, and at [...] …
Federal regulators recently said planned out-of-pocket increases for Medicare beneficiaries are due, in part, to the proposed lump sum payment [...] …
A recent study found positive patient benefits from a 340B cash discount program. Low-income patients said saving money on injectable [...] …
Federal healthcare agencies recently told a federal district judge that backing a South Carolina health center’s interpretation of the 340B [...] …
A fourth drugmaker owes repayment to 340B covered entities, according to final audits posted this week by federal officials. RedHill [...] …
A federal district judge has granted a Chicago hospital an additional 31 days to fight its expulsion from the 340B [...] …
Two hospital advocacy groups are meeting with federal healthcare regulators to press their case for changes in the 340B lump [...] …